Myosin light chain 9 promotes the proliferation, invasion, migration and angiogenesis of colorectal cancer cells by binding to Yes-associated protein 1 and regulating Hippo signaling

References

• Brenner H, Kloor M, Pox CP, et al. Colorectal cancer. Lancet. 2014;383:1490–1502.
   PubMed Web of Science ®Google Scholar
• Stock C, Pulte D, et al. Subsite-specific colorectal cancer risk in the colorectal endoscopy era. Gastrointest Endosc. 2012;75:621–630.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Kasi PM, Shahjehan F, Cochuyt JJ, et al. Rising proportion of young individuals with rectal and colon cancer. Clin Colorectal Cancer. 2019;18:e87–e95.
   PubMed Web of Science ®Google Scholar
• Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019;394:1467–1480.
   PubMed Web of Science ®Google Scholar
• Kruthika BS, Sugur H, Nandaki K, et al. Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma. J Clin Pathol. 2019;72:677–681.
   PubMed Web of Science ®Google Scholar
• Wang JH, Zhang L, Huang ST, et al. Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma. PLoS One. 2017;12:e0175280.
   PubMed Web of Science ®Google Scholar
• Huang YQ, Han ZD, Liang YX, et al. Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer. Med Oncol. 2014;31:820.
   PubMed Web of Science ®Google Scholar
• Tan X, Chen M. MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data. Tumour Biol. 2014;35:12189–12200.
   PubMedGoogle Scholar
• Zhao B, Baloch Z, Ma Y, et al. Identification of potential key genes and pathways in early-onset colorectal cancer through bioinformatics analysis. Cancer Control. 2019;26(1):1073274819831260.
   Web of Science ®Google Scholar
• Qiu X, Cheng SH, Xu F, et al. Weighted gene co-expression network analysis identified MYL9 and CNN1 are associated with recurrence in colorectal cancer. J Cancer. 2020;11:2348–2359.
   PubMed Web of Science ®Google Scholar
• Lee KW, Lee SS, Kim SB, et al. Significant association of oncogene YAP1 with poor prognosis and cetuximab resistance in colorectal cancer patients. Clin Cancer Res. 2015;21:357–364.
   PubMed Web of Science ®Google Scholar
• Shibata M, Ham K, Hoque MO, et al. A time for YAP1: tumorigenesis, immunosuppression and targeted therapy. Int J Cancer. 2018;143:2133–2144.
   PubMed Web of Science ®Google Scholar
• Zhou D, Zhang Y, Wu H, et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci U S A. 2011;108:E1312–1320.
   PubMed Web of Science ®Google Scholar
• Avruch J, Zhou D, Bardeesy N, et al. YAP oncogene overexpression supercharges colon cancer proliferation. Cell Cycle. 2012;11(6):1090–1096.
   PubMed Web of Science ®Google Scholar
• Mickle M, Adhikary G, Shrestha S, et al. VGLL4 inhibits YAP1/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype. Mol Carcinog. 2021;60:497–507.
   PubMed Web of Science ®Google Scholar
• Qi L, Shi C, Li J, et al. Yes-associated protein promotes cell migration via activating Wiskott-Aldrich syndrome protein family member 1 in oral squamous cell carcinoma. J Oral Pathol Med. 2019;48:290–298.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Wang R, Ma Y, Zhan S, et al. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-kappaB pathway to induce VEGFA expression. Cell Death Dis. 2020;11:55.
   PubMed Web of Science ®Google Scholar
• Xiaoxia X, Jing S, Dongbin X, et al. Realgar nanoparticles inhibit migration, invasion and metastasis in a mouse model of breast cancer by suppressing matrix metalloproteinases and angiogenesis. Curr Drug Deliv. 2020;17:148–158.
   PubMed Web of Science ®Google Scholar
• Du F, Li X, Feng W, et al. SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET. Oncogene. 2020;39:3522–3540.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao C, Sun J, et al. Overexpression of small nucleolar RNA SNORD1C is associated with unfavorable outcome in colorectal cancer. Bioengineered. 2021;12:8943–8952.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Bian S, Zhou X, et al. Single-cell multiomics sequencing reveals prevalent genomic alterations in tumor stromal cells of human colorectal cancer. Cancer Cell. 2020;38:818–828 e815.
   PubMed Web of Science ®Google Scholar
• Zhu K, Wang Y, Liu L, et al. Long non-coding RNA MBNL1-AS1 regulates proliferation, migration, and invasion of cancer stem cells in colon cancer by interacting with MYL9 via sponging microRNA-412-3p. Clin Res Hepatol Gastroenterol. 2020;44:101–114.
   PubMed Web of Science ®Google Scholar
• Zhao S, Xiong W, Xu K. MiR-663a, regulated by lncRNA GAS5, contributes to osteosarcoma development through targeting MYL9. Hum Exp Toxicol. 2020;39:1607–1618.
   PubMed Web of Science ®Google Scholar
• Zhang C, Luo X, Liu L, et al. Myocardin-related transcription factor A is up-regulated by 17beta-estradiol and promotes migration of MCF-7 breast cancer cells via transactivation of MYL9 and CYR61. Acta Biochim Biophys Sin (Shanghai). 2013;45:921–927.
   PubMed Web of Science ®Google Scholar
• Zhang X, Shi G, Gao F, et al. TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCgamma. Oncol Rep. 2019;41:2117–2125.
   PubMed Web of Science ®Google Scholar
• Kalhori V, Tornquist K. MMP2 and MMP9 participate in S1P-induced invasion of follicular ML-1 thyroid cancer cells. Mol Cell Endocrinol. 2015;404:113–122.
   PubMed Web of Science ®Google Scholar
• Liu H, Li A, Sun Z, et al. Long non-coding RNA NEAT1 promotes colorectal cancer progression by regulating miR-205-5p/VEGFA axis. Hum Cell. 2020;33:386–396.
   PubMed Web of Science ®Google Scholar
• Franco CA, Blanc J, Parlakian A, et al. SRF selectively controls tip cell invasive behavior in angiogenesis. Development. 2013;140:2321–2333.
   PubMed Web of Science ®Google Scholar
• Chu CY, Chang CC, et al. Connective tissue growth factor (CTGF) and cancer progression. J Biomed Sci. 2008;15:675–685.
   PubMed Web of Science ®Google Scholar
• Warren JSA, Xiao Y, Lamar JM. YAP/TAZ activation as a target for treating metastatic cancer. Cancers (Basel). 2018;10:115.
   PubMed Web of Science ®Google Scholar
• Steinhardt AA, Gayyed MF, Klein AP, et al. Expression of Yes-associated protein in common solid tumors. Hum Pathol. 2008;39:1582–1589.
   PubMed Web of Science ®Google Scholar
• Song S, Li Y, Xu Y, et al. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma. Mol Oncol. 2020;14:1410–1426.
   PubMed Web of Science ®Google Scholar
• Harvey KF, Zhang X, Thomas DM, et al. The Hippo pathway and human cancer. Nat Rev Cancer. 2013;13:246–257.
   PubMed Web of Science ®Google Scholar
• Wang H, Di X, Bi Y, et al. Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p. Bioengineered. 2021;12:1791–1802.
   PubMed Web of Science ®Google Scholar